Omniome Inc, San Diego-based developer of DNA sequencing technology, has raised a $60 million Series B round led by Shanghai private equity firm Decheng Capital and Asia-focused Hillhouse Capital Group, the company announced.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
